Sanford studying immunotherapy drug for esophageal cancer
A clinical trial at Sanford Health is studying if an immunotherapy drug developed by Merck might be able to treat certain patients with advanced esophageal cancer. The Merck Keynote 181 trial is now open at Sanford. The study is exploring the Merck drug pembrolizumab, an immune checkpoint inhibitor that allows the body to recognize the […]
⋅ 3 min read
Sanford, Good Samaritan Society name new joint venture
In July, Sanford Health and the Good Samaritan Society announced a joint venture to improve senior services in the Bismarck-Mandan area. The joint venture includes a new 120-bed rehabilitation/skilled care center being built in southeast Mandan, Sanford Health Sunset Drive Continuing Care Center, Sanford Health St. Vincent’s Continuing Care Center and the Good Samaritan Society […]
⋅ 4 min read
